You just read:

Immune Checkpoint Inhibitors Market is Anticipated to Cross US$ 25 Billion by 2022 Due to Increasing Prevalence of Cancer and Immune Diseases: Radiant Insights, Inc.

News provided by

Radiant Insights, Inc.

10 Oct, 2018, 13:10 BST